Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 262

1.

Response.

Januszewicz W, Regula J.

Gastrointest Endosc. 2019 Sep;90(3):538-539. doi: 10.1016/j.gie.2019.05.006. No abstract available.

PMID:
31439140
2.

A clinically translatable hyperspectral endoscopy (HySE) system for imaging the gastrointestinal tract.

Yoon J, Joseph J, Waterhouse DJ, Luthman AS, Gordon GSD, di Pietro M, Januszewicz W, Fitzgerald RC, Bohndiek SE.

Nat Commun. 2019 Apr 23;10(1):1902. doi: 10.1038/s41467-019-09484-4.

3.

A sinister black finding in the stomach.

Januszewicz W, Corrie P, Liu H, Chan J, Fitzgerald RC, di Pietro M.

Lancet. 2019 Mar 16;393(10176):1149. doi: 10.1016/S0140-6736(19)30423-4. Epub 2019 Mar 14. No abstract available.

PMID:
30894270
4.

Early detection and therapeutics.

Januszewicz W, Fitzgerald RC.

Mol Oncol. 2019 Mar;13(3):599-613. doi: 10.1002/1878-0261.12458. Epub 2019 Feb 20. Review.

5.

Endoscopist biopsy rate as a quality indicator for outpatient gastroscopy: a multicenter cohort study with validation.

Januszewicz W, Wieszczy P, Bialek A, Karpinska K, Szlak J, Szymonik J, Rupinski M, Mroz A, Regula J, Kaminski MF.

Gastrointest Endosc. 2019 Jun;89(6):1141-1149. doi: 10.1016/j.gie.2019.01.008. Epub 2019 Jan 17.

PMID:
30659831
6.

Bimodal reflectance and fluorescence multispectral endoscopy based on spectrally resolving detector arrays.

Luthman AS, Waterhouse DJ, Ansel-Bollepalli L, Yoon J, Gordon GSD, Joseph J, di Pietro M, Januszewicz W, Bohndiek SE.

J Biomed Opt. 2018 Oct;24(3):1-14. doi: 10.1117/1.JBO.24.3.031009.

7.

Safety and Acceptability of Esophageal Cytosponge Cell Collection Device in a Pooled Analysis of Data From Individual Patients.

Januszewicz W, Tan WK, Lehovsky K, Debiram-Beecham I, Nuckcheddy T, Moist S, Kadri S, di Pietro M, Boussioutas A, Shaheen NJ, Katzka DA, Dellon ES, Fitzgerald RC; BEST1 and BEST2 study investigators.

Clin Gastroenterol Hepatol. 2019 Mar;17(4):647-656.e1. doi: 10.1016/j.cgh.2018.07.043. Epub 2018 Aug 9.

8.

Long esophageal inlet patch as a rare cause of laryngopharyngeal symptoms.

Januszewicz W, Pietrzak A, Lenarcik M, Mróz A, Reguła J.

Endoscopy. 2018 Mar;50(3):E61-E62. doi: 10.1055/s-0043-123823. Epub 2017 Dec 15. No abstract available.

PMID:
29245163
9.

Immunohistochemical features and staging of early gastric cancer.

Gurzu S, Orlowska J, Sugimura H, Bara T, Szentirmay Z, Januszewicz W, Bara T Jr, Szederjesi J, Jung I.

Arch Med Sci. 2017 Oct;13(6):1373-1382. doi: 10.5114/aoms.2016.58665. Epub 2016 Mar 22.

10.

An international survey of polypectomy training and assessment.

Patel K, Rajendran A, Faiz O, Rutter MD, Rutter C On Behalf Of Bsg Trainees Section, Jover R, Koutroubakis I, Januszewicz W, Ferlitsch M, Dekker E, MacIntosh D, Ng SC, Kitiyakara T, Pohl H, Thomas-Gibson S.

Endosc Int Open. 2017 Mar;5(3):E190-E197. doi: 10.1055/s-0042-119949.

11.

Adenocarcinoma risk in patients registered with Polish Barrett's Oesophagus Registry.

Januszewicz W, Kaminski MF, Wieszczy P, Wronska E, Bielasik A, Wojciechowska U, Didkowska J, Orlowska J, Regula J.

Dis Esophagus. 2017 Jan 1;30(1):1-6. doi: 10.1111/dote.12483.

PMID:
27377059
12.

Hereditary hemorrhagic telangiectasias as a rare cause of recurrent gastrointestinal bleeding.

Januszewicz W, Jóźwik-Plebanek K, Wrońska E, Kabat M, Januszewicz A, Reguła J.

Pol Arch Med Wewn. 2016 May 31;126(5):363-4. doi: 10.20452/pamw.3412. Epub 2016 May 27. No abstract available.

13.

Malignant hypertension: new aspects of an old clinical entity.

Januszewicz A, Guzik T, Prejbisz A, Mikołajczyk T, Osmenda G, Januszewicz W.

Pol Arch Med Wewn. 2016;126(1-2):86-93. Review.

14.

Tribute to John H. Laragh by Włodzimierz Januszewicz and Andrzej Januszewicz.

Januszewicz W, Januszewicz A.

Pol Arch Med Wewn. 2015;125(9):606. No abstract available.

15.

In memoriam: Dr. John H. Laragh.

Januszewicz W, Januszewicz A.

Pol Arch Med Wewn. 2015;125(9):605. No abstract available.

16.

[Pathogenesis of essential hypertension--a half of the century perspective].

Januszewicz W, Kabat M, Prejbisz A, Januszewicz A.

Pol Merkur Lekarski. 2014 Jan;36(211):7-10. Polish.

PMID:
24645570
17.

Primary aldosteronism - recent progress and current concepts.

Kołodziejczyk-Kruk S, Januszewicz W, Pęczkowska M, Prejbisz A, Zgliczyński W, Januszewicz A.

Endokrynol Pol. 2013;64(4):312-8. Review.

18.

[Wanda Wysznacka-Aleksandrow (1920-2009)].

Dyduszyński A, Januszewicz W, Sznajderman M.

Kardiol Pol. 2009 May;67(5):589-90. Polish. No abstract available.

PMID:
19610256
19.

Felodipine-metoprolol combination tablet: maintained health-related quality of life in the presence of substantial blood pressure reduction.

Dahlöf B, Degl' Innocenti A, Elmfeldt D, Puig JG, Gundersen T, Hosie J, Januszewicz W, Lindström CJ, Magometschnigg D, Tanser P, Toutouzas P, Waeber B, Wiklund I.

Am J Hypertens. 2005 Oct;18(10):1313-9.

PMID:
16202854
20.

[Blood pressure reduction in hypertension--what is the optimal target value?].

Januszewicz W, Januszewicz A.

Kardiol Pol. 2004 Nov;61(11):505-10. Review. Polish. No abstract available.

PMID:
15883611
21.

The effects of genetic factors on selected indicators of the activity of the sympathoadrenal system and the renin-angiotensin-aldosterone system in twins.

Jedrusik P, Januszewicz A, Busjahn A, Wocial B, Ignatowska-Switalska H, Strelau J, C Luft F, Januszewicz W.

Kardiol Pol. 2004 Nov;61(11):423-9; discussion 430. English, Polish.

PMID:
15883590
22.

Plasma neuropeptide Y immunoreactivity influences left ventricular mass in pheochromocytoma.

Kuch-Wocial A, Slubowska K, Kostrubiec M, Pasierski T, Januszewicz W, Switalska H, Wocial B, Pruszczyk P.

Clin Chim Acta. 2004 Jul;345(1-2):43-7.

PMID:
15193976
23.

[Rare forms of hypertension].

Januszewicz A, Januszewicz W, Dworzański W, Prejbisz A.

Pol Merkur Lekarski. 2003 Nov;15(89):452-4. Review. Polish.

PMID:
14969142
24.

Genetic influence on blood pressure and lipid parameters in a sample of Polish twins.

Jedrusik P, Januszewicz A, Busjahn A, Zawadzki B, Wocial B, Ignatowska-Switalska H, Berent H, Kuczyńska K, Oniszczenko W, Strelau J, Luft FC, Januszewicz W.

Blood Press. 2003;12(1):7-11.

PMID:
12699129
25.

[Advances in the therapy of hypertension].

Januszewicz W.

Pol Merkur Lekarski. 2002 Nov;13 Suppl 1:7-8; discussion 8-10. Polish. No abstract available.

PMID:
12621773
26.

Do catecholamines influence the level of plasma leptin in patients with phaeochromocytoma?

Wocial B, Ignatowska-Switalska H, Berent H, Dutkiewicz-Raczkowska M, Kuczyńska K, Chodakowska J, Feltynowski T, Januszewicz W, Szostek M, Cieśla W.

Br J Biomed Sci. 2002;59(3):141-4.

PMID:
12371054
27.

Dopamine and dopa urinary excretion in patients with pheochromocytoma--diagnostic implications.

Januszewicz W, Wocial B, Januszewicz A, Gryglas P, Prejbisz A.

Blood Press. 2001;10(4):212-6.

PMID:
11800059
28.

Immunomorphological studies and cytometric DNA ploidy in diagnostics of pheochromocytoma.

Maryniak RK, Szczałuba K, Ignatowska-Switalska M, Wocial B, Januszewicz W.

Pol J Pathol. 2000;51(2):83-6.

PMID:
10974931
29.

Incidence and clinical relevance of RET proto-oncogene germline mutations in pheochromocytoma patients.

Januszewicz A, Neumann HP, Loń I, Szmigielski C, Symonides B, Kabat M, Apel TW, Wocial B, Lapiński M, Januszewicz W.

J Hypertens. 2000 Aug;18(8):1019-23.

PMID:
10953992
30.

[Contemporary rules for diagnosing hypertension].

Januszewicz W.

Pol Arch Med Wewn. 1999 Mar;101(3):185-9. Polish. No abstract available.

PMID:
10697393
31.

Effects of the correction of renal artery stenosis on blood pressure, renal function and left ventricular morphology.

Symonides B, Chodakowska J, Januszewicz A, Lapinski M, Januszewicz M, Rowiński O, Szmidt J, Kuch-Wocial A, Kurzyna M, Małek G, Berent H, Szmigielski C, Januszewicz W.

Blood Press. 1999;8(3):141-50.

PMID:
10595691
32.

Felodipine-metoprolol combination tablet: a valuable option to initiate antihypertensive therapy?

Waeber B, Detry JM, Dahlöf B, Puig JG, Gundersen T, Hosie J, Januszewicz W, Lindström CJ, Magometschnigg D, Safar M, Tanser P, Toutouzas P.

Am J Hypertens. 1999 Sep;12(9 Pt 1):915-20.

PMID:
10509550
33.

Plasma fibrinogen as a risk factor for restenosis after percutaneous transluminal renal angioplasty in patients with atherosclerotic renal artery stenosis.

Symonides B, Januszewicz A, Rowinski O, Januszewicz M, Chodakowska J, Berent H, Kuczynska K, Szmigielski C, Malek G, Januszewicz W.

J Cardiovasc Risk. 1999 Aug;6(4):269-72.

PMID:
10501280
34.

[Hypertension and atherosclerosis].

Jedrusik P, Berent H, Kuczyńska K, Januszewicz W.

Pol Arch Med Wewn. 1998 Jun;99(6):507-12. Review. Polish. No abstract available.

PMID:
10085706
35.

Blood pressure, plasma NPY and catecholamines during physical exercise in relation to menstrual cycle, ovariectomy, and estrogen replacement.

Lewandowski J, Pruszczyk P, Elaffi M, Chodakowska J, Wocial B, Switalska H, Januszewicz W, Zukowska-Grojec Z.

Regul Pept. 1998 Sep 25;75-76:239-45.

PMID:
9802415
36.

Alterations in plasma neuropeptide Y immunoreactivity and catecholamine levels during surgical removal of pheochromocytoma.

Januszewicz W, Wocial B, Ignatowska-Switalska H, Dutkiewicz-Raczkowska M, Feltynowski T, Januszewicz A, Tapiński M, Zukowska-Grójec Z, Szostek M.

J Hypertens. 1998 Apr;16(4):543-7.

PMID:
9797201
37.

Secondary hypertension in the elderly.

Januszewicz W, Chodakowska J, Styczyński G.

J Hum Hypertens. 1998 Sep;12(9):603-6. Review.

PMID:
9783488
38.

Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.

Sadowski Z, Szwed H, Kuch-Wocial A, Kubasik A, Januszewicz W, Krupa-Wojciechowska B, Polak G, Stejfa M, Dvorak I, Balazovjech I, Dubai G, Simon K.

J Hypertens Suppl. 1998 Aug;16(3):S55-62.

PMID:
9747912
39.

[Secondary hypertension in the elderly].

Januszewicz W, Chodakowska J, Styczyński G.

Pol Arch Med Wewn. 1997 Nov;98(11):470-5. Review. Polish. No abstract available.

PMID:
9594567
40.

Hemorrheological indices, catecholamines, neuropeptide Y and serotonin in patients with essential hypertension.

Berent H, Kuczyńska K, Kochmański M, Wocial B, Lapiński M, Lewandowski J, Januszewicz A, Ignatowska-Switalska H, Januszewicz W.

Blood Press. 1997 Jul;6(4):203-8.

PMID:
9296306
41.

Evaluation of plasma aldosterone to plasma renin activity ratio in patients with primary aldosteronism.

Ignatowska-Switalska H, Chodakowska J, Januszewicz W, Feltynowski T, Adamczyk M, Lewandowski J.

J Hum Hypertens. 1997 Jun;11(6):373-8.

PMID:
9249232
42.

[Evaluation of the usefulness for measuring catecholamines and their principle metabolites in the diagnosis of pheochromocytoma].

Wocial B, Januszewicz W, Gryglas P, Januszewicz A, Feltynowski T, Lapiński M.

Przegl Lek. 1997;54(11):793-8. Polish.

PMID:
9501691
43.

[Pheochromocytoma with hemorrhagic necrosis and rupture with symptoms of acute abdomen and shock].

Chlebus M, Lapiński M, Torbicki A, Chlebus H, Szostek M, Wocial B, Staszkiewicz W, Januszewicz W.

Pol Arch Med Wewn. 1996 Jul;96(1):58-61. Polish.

PMID:
8966147
44.

Plasma erythropoietin concentration in patients with pheochromocytoma.

Januszewicz A, Lewandowski J, Lapiński M, Trzepla E, Kuczyńska K, Berent H, Chodakowska J, Wocial B, Januszewicz W.

J Hum Hypertens. 1996 Jul;10(7):497-8. No abstract available.

PMID:
8880567
45.

[Evaluation of blood rheology indices in patients with pheochromocytoma].

Berent H, Wocial B, Kuczyńska K, Kochmański M, Ignatowska-Switalska H, Januszewicz A, Lapiński M, Lewandowski J, Januszewicz W.

Pol Arch Med Wewn. 1996 Mar;95(3):190-7. Polish.

PMID:
8755848
46.

Pathogenesis of essential hypertension--present views.

Januszewicz W, Chodakowska J.

Pol J Pharmacol. 1996 Jan-Feb;48(1):61-5. Review.

PMID:
9112629
47.

Does plasma neuropeptide-Y immunoreactivity in patients with pheochromocytoma depend on hormonal activity of the tumor?

Pruszczyk P, Wocial B, Ignatowska-Switalska H, Feltynowski T, Ellafi M, Januszewicz A, Lapiński M, Zukowska-Grojec Z, Januszewicz W.

Clin Chim Acta. 1995 Dec 29;243(2):205-12. No abstract available.

PMID:
8747495
48.

Influence of alpha-adrenergic blockade on ventricular arrhythmias, QTc interval and heart rate variability in phaeochromocytoma.

Dabrowska B, Pruszczyk P, Dabrowski A, Feltynowski T, Wocial B, Januszewicz W.

J Hum Hypertens. 1995 Nov;9(11):925-9.

PMID:
8583473
49.

Pheochromocytoma--the catecholamine dependent hypertension.

Januszewicz W, Wocial B.

J Physiol Pharmacol. 1995 Sep;46(3):285-95.

PMID:
8527810
50.

Plasma neuropeptide Y and catecholamines in women and men with essential hypertension.

Wocial B, Ignatowska-Switalska H, Pruszczyk P, Jedrusik P, Januszewicz A, Lapinski M, Januszewicz W, Zukowska-Grojec Z.

Blood Press. 1995 May;4(3):143-7.

PMID:
7670647

Supplemental Content

Loading ...
Support Center